![]() Societal CDMO Recro Gainesville (also known as Recro Pharma) is a clinical-stage specialty pharmaceutical company developing non-opioid therapeutics for the treatment of acute post-operative pain. | ![]() Biofrontera Biofrontera is a biopharmaceutical company that specializes in the development and commercialization of dermatological medications and medical cosmetics. | |||
Founding Date | Founding Date 2006 | Founding Date 1948 | Founding Date 2012 | Founding Date 1996 |
Type | Type Public | Type Subsidiary | Type Public | Type Subsidiary |
Tags | ||||
Locations | Locations Gainesville, US HQ Gainesville, US San Diego, US | Locations Leverkusen, DE HQ | Locations Saint-Quentin-Fallavier, FR HQ | |
Employees | Employees 21316% decrease | Employees 650 | Employees 91 | Employees 2453% increase |
Valuation ($) | Valuation ($) 116.1 m | Valuation ($) N/A | Valuation ($) 1.1 m | Valuation ($) N/A |
Financial | ||||
Revenue (est.) | Revenue (est.) $94.6m (FY, 2023) | Revenue (est.) £731.3m (FY, 2019) | Revenue (est.) €13.2m (FY, 2025) | Revenue (est.) £95.9m (FY, 2015) |
Cost of goods | Cost of goods $76.5m (FY, 2023) | Cost of goods £221m (FY, 2019) | Cost of goods €2.2m (FY, 2025) | Cost of goods £43.1m (FY, 2015) |
Gross profit | Gross profit N/A | Gross profit £510.3m (FY, 2019) | Gross profit €11.2m (FY, 2025) | Gross profit £52.8m (FY, 2015) |
Net income | Net income ($13.3m) (FY, 2023) | Net income £88.3m (FY, 2019) | Net income (€6.9m) (FY, 2025) | Net income N/A |

Biofrontera is a biopharmaceutical company that specializes in the development and commercialization of dermatological medications and medical cosmetics.
View company
Skyepharma is a drug delivery company developing oral and inhalation products.
View company